XML 60 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Acquisitions (Tables)
 12 Months Ended
Jun. 30, 2017
Business Combinations [Abstract]  
Estimated Fair Values of Assets Acquired and Liabilities Assumed
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed as of the acquisition dates for Cordis, naviHealth and Harvard Drug:
(in millions)
Cordis
 
naviHealth
 
Harvard Drug
Identifiable intangible assets:
 
 
 
 
 
Customer relationships (1)
$
225

 
$
38

 
$
470

Trade names (2)
125

 
16

 
130

Developed technology (3)
395

 
61

 
—

In-process research and development (4)
55

 
—

 
—

Total identifiable intangible assets acquired
800

 
115

 
600

 
 
 
 
 
 
Cash and equivalents
—

 
53

 
44

Trade receivables
—

 
31

 
67

Inventories
205

 
—

 
49

Prepaid expenses and other
4

 
14

 
11

Property and equipment
97

 
5

 
16

Other assets
44

 
1

 
—

Accounts payable
(82
)
 
(2
)
 
(47
)
Other accrued liabilities
(85
)
 
(95
)
 
(37
)
Deferred income taxes and other liabilities
(13
)
 
(33
)
 
(188
)
Redeemable noncontrolling interests
—

 
(119
)
 
—

Total identifiable net assets/(liabilities) acquired
970

 
(30
)
 
515

Goodwill
914

 
321

 
634

Total net assets acquired
$
1,884

 
$
291

 
$
1,149

(1)
The weighted-average useful lives of customer relationships range from 4 to 13 years.
(2)
The weighted-average useful lives of trade names range from 10 to 20 years.
(3)
The weighted-average useful life of developed technology is 10 years.
(4)
Acquired in-process research and development intangible assets have an indefinite life.